ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 60 filers reported holding ESSA PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,310,000 | -49.0% | 2,003,103 | 0.0% | 0.02% | -32.3% |
| Q1 2022 | $12,379,000 | -73.6% | 2,003,103 | -39.4% | 0.03% | -73.5% |
| Q4 2021 | $46,904,000 | +77.5% | 3,303,103 | 0.0% | 0.12% | +98.3% |
| Q3 2021 | $26,425,000 | -72.0% | 3,303,103 | 0.0% | 0.06% | -72.3% |
| Q2 2021 | $94,370,000 | -9.1% | 3,303,103 | -7.6% | 0.21% | +2.9% |
| Q1 2021 | $103,797,000 | +143.5% | 3,573,053 | 0.0% | 0.21% | +38.0% |
| Q4 2020 | $42,627,000 | +72.9% | 3,573,053 | 0.0% | 0.15% | +56.2% |
| Q3 2020 | $24,654,000 | +17.9% | 3,573,053 | +5.9% | 0.10% | +9.1% |
| Q2 2020 | $20,913,000 | +55.0% | 3,373,053 | 0.0% | 0.09% | -10.2% |
| Q1 2020 | $13,492,000 | -27.3% | 3,373,053 | 0.0% | 0.10% | -19.0% |
| Q4 2019 | $18,552,000 | +63.2% | 3,373,053 | 0.0% | 0.12% | +86.2% |
| Q3 2019 | $11,367,000 | +178.1% | 3,373,053 | +102.2% | 0.06% | +209.5% |
| Q2 2019 | $4,088,000 | -27.9% | 1,668,560 | 0.0% | 0.02% | -25.0% |
| Q1 2019 | $5,673,000 | +61.9% | 1,668,560 | 0.0% | 0.03% | +40.0% |
| Q4 2018 | $3,504,000 | – | 1,668,560 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |